Cargando…
Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
BACKGROUND: Respiratory distress syndrome (RDS) is a common disease that seriously endangers the life and safety of newborns, especially premature infants. Exogenous pulmonary surfactant (PS) is the specific agent for the treatment of neonatal RDS. Lung ultrasound (LUS) has been successfully used in...
Autores principales: | Liu, Jing, Fu, Wei, Qin, Shen-Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635001/ https://www.ncbi.nlm.nih.gov/pubmed/36340730 http://dx.doi.org/10.3389/fped.2022.952315 |
Ejemplares similares
-
FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021) -
Outcome of Very Premature Newborn Receiving an Early Second Dose of Surfactant for Persistent Respiratory Distress Syndrome
por: Greiner, Eva, et al.
Publicado: (2021) -
Ultrasound to guided epicutaneo-caval catheter insertion in newborn infants
por: Ren, Xiao-Ling, et al.
Publicado: (2022) -
Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
por: Han, Tongyan, et al.
Publicado: (2020) -
Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)